Revenue | ₹44.84Cr |
Net Profits | ₹5.93Cr |
Net Profit Margins | 13.22% |
Jenburkt Pharmaceuticals Ltd’s revenue jumped 16.56% since last year same period to ₹44.84Cr in the Q3 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -5.88% fall in its revenue since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit fell -8.91% since last year same period to ₹5.93Cr in the Q3 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -41.63% fall in its net profits since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit margin fell -21.85% since last year same period to 13.22% in the Q3 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -37.99% fall in its net profit margins since last 3-months.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q3 results 2025 was ₹44.84Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q3 results 2025 was ₹5.93Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q3 results 2025 was 13.22%.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was ₹38.47Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was ₹6.51Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was 16.92%.